# Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

Study · id `cardio:ct-nct04542148` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04542148](<https://clinicaltrials.gov/study/NCT04542148>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04542148

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04542148. Randomized; no masking; primary purpose treatment. Start 2022-02-10 (actual); primary completion 2025-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04542148, source copy `cardio:ctgov-nct04542148-2026-07-14`, retrieved 2026-10-26)
- Started: 2022-02-10 (actual) (ClinicalTrials.gov record NCT04542148, source copy `cardio:ctgov-nct04542148-2026-07-14`, retrieved 2026-10-26)
- Primary completion: 2025-11-30 (actual) (ClinicalTrials.gov record NCT04542148, source copy `cardio:ctgov-nct04542148-2026-07-14`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT04542148, source copy `cardio:ctgov-nct04542148-2026-07-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04542148, source copy `cardio:ctgov-nct04542148-2026-07-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04542148-2026-07-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
- Condition: Diabetes Mellitus, Type 2
- Condition: Preterm Birth
- Condition: Pregnancy, High Risk
- Condition: Diabetes, Gestational
- Intervention (Drug): Sliding Scale Insulin
- Intervention (Drug): Up-Titration of Home Insulin
- Intervention (Drug): Continuous Insulin Infusion
- Intervention (Device): Dexcom G6 Professional Continuous Glucose Monitor
- Lead sponsor: University of Alabama at Birmingham
- Lead sponsor class: OTHER
- Collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Alabama at Birmingham (`cardio:org-university-of-alabama-at-birmingham`)
- Registry lists this organization as a collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (`cardio:org-eunice-kennedy-shriver-national-institute-of-child-health-7cbc9f`)

## Provenance

Content hash: d98b247df787c6bc013286755f21cd0de95310f61c9584c672a6c1dad36f140f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
